Peter Ernst Huber
German Cancer Research Center · 403 works · 16,387 citations · h-index 66
Top works
- Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
- Brain tumour cells interconnect to a functional and resistant network
- Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis
- A new noninvasive approach in breast cancer therapy using magnetic resonance imaging-guided focused ultrasound surgery.
- Endostatin's Antiangiogenic Signaling Network
- A new concept for interactive radiotherapy planning with multicriteria optimization: First clinical evaluation
- Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam?
- In vitro and in vivo transfection of plasmid DNA in the Dunning prostate tumor R3327-AT1 is enhanced by focused ultrasound
- Transcriptional network governing the angiogenic switch in human pancreatic cancer
- Trimodal Cancer Treatment: Beneficial Effects of Combined Antiangiogenesis, Radiation, and Chemotherapy
- Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET
- Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): Long-term results in 106 patients treated in a single institution
- Inhibition of αvβ3 Integrin Survival Signaling Enhances Antiangiogenic and Antitumor Effects of Radiotherapy
- Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers
- Pancreatic cancer microenvironment
- IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein–specific PET/CT
- Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas
- Quantitative MR temperature monitoring of high-intensity focused ultrasound therapy
- Transcriptional Switch of Dormant Tumors to Fast-Growing Angiogenic Phenotype
- SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro.